These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1450934)

  • 21. Cerebral metabolic effects of sigma ligands in the rat.
    della Puppa A; London ED
    Brain Res; 1989 Dec; 505(2):283-90. PubMed ID: 2557134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic response to tacrine (THA) and physostigmine in the aged rat brain.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):1093-102. PubMed ID: 7593342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose utilization in the Papez circuit: effects of oxotremorine and scopolamine.
    Dam M; London ED
    Brain Res; 1984 Mar; 295(1):137-44. PubMed ID: 6713172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local cerebral glucose utilization in adult and immature GAERS.
    Nehlig A; Vergnes M; Boyet S; Marescaux C
    Epilepsy Res; 1998 Sep; 32(1-2):206-12. PubMed ID: 9761321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local cerebral glucose utilization in the free moving mouse: a comparison during two stages of the activity-rest cycle.
    Jay TM; Jouvet M; des Rosiers MH
    Brain Res; 1985 Sep; 342(2):297-306. PubMed ID: 4041831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography.
    Jordan GR; McCulloch J; Shahid M; Hill DR; Henry B; Horsburgh K
    Neuropharmacology; 2005 Aug; 49(2):254-64. PubMed ID: 15993447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulatory effect of the D2 antagonist sulpiride on glucose utilization in dopaminergic regions of rat brain.
    Pizzolato G; Soncrant TT; Larson DM; Rapoport SI
    J Neurochem; 1987 Aug; 49(2):631-8. PubMed ID: 2955080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sigma ligand 1,3-di-o-tolylguanidine depresses amino acid-induced excitation non-selectively in rat brain.
    Connick JH; Addae JI; Nicholson CD; Stone TW
    Eur J Pharmacol; 1992 Apr; 214(2-3):169-73. PubMed ID: 1325354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands.
    Patrick SL; Walker JM; Perkel JM; Lockwood M; Patrick RL
    Eur J Pharmacol; 1993 Feb; 231(2):243-9. PubMed ID: 8453980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of mu and kappa opioid analgesics on cerebral glucose utilization in the rat.
    Fanelli RJ; Szikszay M; Jasinski DR; London ED
    Brain Res; 1987 Oct; 422(2):257-66. PubMed ID: 2445439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic mapping of the forelimb motor system in the rat: local cerebral glucose utilization following execution of forelimb movements mainly involving proximal musculature.
    Ebrahimi-Gaillard A; Beck T; Wree A; Roger M
    Somatosens Mot Res; 1994; 11(3):229-41. PubMed ID: 7887055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats.
    Carpenter TL; Pazdernik TL; Levant B
    Brain Res; 2003 Feb; 964(2):295-301. PubMed ID: 12576190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
    Bergeron R; de Montigny C; Debonnel G
    Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local cerebral glucose utilization during waking and slow wave sleep in the cat. A [14C]deoxyglucose study.
    Petitjean F; Seguin S; Des Rosiers MH; Salvert D; Buda C; Janin M; Debilly G; Jouvet M; Bobillier P
    Neurosci Lett; 1982 Sep; 32(1):91-7. PubMed ID: 7145230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain hyperthermia alters local cerebral glucose utilization: a comparison of hyperthermic agents.
    Mickley GA; Cobb BL; Farrell ST
    Int J Hyperthermia; 1997; 13(1):99-114. PubMed ID: 9024931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol-naïve alcohol-preferring (P) rats exhibit higher local cerebral glucose utilization than alcohol-nonpreferring (NP) and Wistar rats.
    Smith DG; Learn JE; McBride WJ; Lumeng L; Li TK; Murphy JM
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1309-16. PubMed ID: 11584150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test.
    Skuza G; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):329-35. PubMed ID: 9566032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of an acute nicotine infusion on the local cerebral glucose utilization of the awake rat.
    Grünwald F; Schröck H; Kuschinsky W
    Klin Wochenschr; 1988; 66 Suppl 11():37-41. PubMed ID: 3184778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered quinpirole-induced local cerebral glucose utilization in anterior cortical regions in rats after sensitization to quinpirole.
    Richards TL; Pazdernik TL; Levant B
    Brain Res; 2005 Apr; 1042(1):53-61. PubMed ID: 15823253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats.
    Pontieri FE; Crane AM; Seiden LS; Kleven MS; Porrino LJ
    Psychopharmacology (Berl); 1990; 102(2):175-82. PubMed ID: 1980372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.